scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Nieto FJ | |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 937-948 | |
P577 | publication date | 1998-11-01 | |
P1433 | published in | American Journal of Epidemiology | Q4744243 |
P1476 | title | Infections and atherosclerosis: new clues from an old hypothesis? | |
P478 | volume | 148 |
Q36899153 | A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease |
Q37873319 | Antibiotic use and risk of ischemic stroke in the elderly |
Q31440267 | Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data |
Q43424356 | Atherosclerosis and tuberculosis: are they both chronic infectious diseases? |
Q33239820 | Atherosclerosis research from past to present--on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow |
Q33935003 | Background and current knowledge of Chlamydia pneumoniae and atherosclerosis |
Q41721897 | C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients |
Q74603701 | Cardiovascular disease and risk factor epidemiology: a look back at the epidemic of the 20th century |
Q35403093 | Childhood housing conditions and later mortality in the Boyd Orr cohort |
Q33905858 | Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies |
Q33934999 | Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment |
Q35696285 | Chlamydia pneumoniae and coronary artery disease: legitimized linkages? |
Q33890410 | Chlamydia pneumoniae in atherosclerosis |
Q38695606 | Chronic hepatitis C virus infection, a new cardiovascular risk factor? |
Q52297206 | Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing |
Q40129907 | Cilostazol attenuates MCP-1 and MMP-9 expression in vivo in LPS-administrated balloon-injured rabbit aorta and in vitro in LPS-treated monocytic THP-1 cells |
Q45759369 | Correlation between the severity of periodontitis and coronary artery stenosis in a Chinese population |
Q36765175 | Cytomegalovirus is associated with reduced telomerase activity in the Whitehall II cohort |
Q33987842 | Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. |
Q36612606 | Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review |
Q33935008 | Epidemiologic association of Chlamydia pneumoniae and atherosclerosis: the initial serologic observation and more |
Q64989524 | Evaluation of cerebrovascular reactivity in chronic hepatitis C patients using transcranial color Doppler. |
Q38899840 | From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease |
Q45130861 | Further evidence of the association between periodontal conditions and coronary artery disease |
Q47395433 | Generational Differences in the 5-Year Incidence of Age-Related Macular Degeneration |
Q37868665 | Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography |
Q47548572 | Impact of hepatitis C virus infection on long-term mortality after acute myocardial infarction: a nationwide population-based, propensity-matched cohort study in Taiwan |
Q35592634 | In-hospital stroke |
Q34522585 | Incidence of first ever stroke during Hajj ceremony |
Q33921219 | Infections and atherosclerosis |
Q38077322 | Inflammation and atherosclerosis: direct versus indirect mechanisms |
Q34316462 | Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand? |
Q43426743 | Is atherosclerosis an infectious disease |
Q35145332 | Is periodontitis associated with an increased risk of coronary heart disease and preterm and/or low birth weight births? |
Q33634694 | Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study |
Q30377539 | Long-term trends in cardiovascular disease mortality and association with respiratory disease. |
Q43936888 | Low socioeconomic status and coronary artery disease |
Q34286610 | Microbes, inflammation and atherosclerosis: will old pathology lessons guide new therapies? |
Q39980119 | New polyphenolic beta-lactams with antioxidant activity |
Q35171753 | Oral infections and systemic diseases |
Q44151857 | Periodontal disease burden and pathological changes in organs of dogs |
Q34354157 | Periodontal diseases and the risk of coronary heart and cerebrovascular diseases: a meta-analysis |
Q35660150 | Periodontitis and coronary artery disease: a questioned association between periodontal and vascular plaques. |
Q34465370 | Potential infectious etiologies of atherosclerosis: a multifactorial perspective |
Q37872836 | Relation of antibiotic use to risk of myocardial infarction in the general population |
Q35504161 | Respiratory disease and cardiovascular morbidity |
Q37251214 | Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III |
Q30234507 | Socioeconomic status in childhood and C reactive protein in adulthood: a systematic review and meta-analysis |
Q59041105 | The Infection Hypothesis Revisited: Oral Infection and Cardiovascular Disease |
Q36352048 | The role of infection and immunity in atherosclerosis |
Q73382390 | Vaccination against infections by Chlamydia pneumoniae |
Q33762104 | Viruses and atherosclerosis: a critical review of the epidemiologic evidence |
Q74310027 | [Infections and arteriosclerosis: science or fiction?] |
Q74436270 | [Role of infectious agents in the understanding of atherosclerosis] |
Search more.